Founded in 2024, AEVUM is a London-based research organisation specialising in the evaluation and supply of selected peptide compounds and laboratory materials. Over the past two years, our work has focused on examining peptides used within international research settings, reviewing their analytical quality, stability, handling requirements and suitability for responsible supply within the UK research market. We combine scientific curiosity with a highly selective approach, favouring a focused catalogue rather than offering every emerging compound without sufficient consideration.

Our current research portfolio centres on GHK-Cu, NAD+, BPC-157 and retatrutide, each selected because of the significant scientific interest surrounding its respective biological pathways. AEVUM works closely with bespoke businesses, laboratories and professional research partners to provide clearly labelled compounds for controlled laboratory research purposes only, and all business enquiries are considered individually to ensure that supply remains aligned with appropriate research use.